Alexis J. Gilman
Overview
Companies seeking antitrust clearance for their mergers and acquisitions, or that are parties or third parties in investigations and litigation launched by the Federal Trade Commission, the Antitrust Division of the Department of Justice, or state attorneys general, turn to Alexis Gilman for experienced and effective antitrust counsel. Alexis leverages years of experience at the FTC, including three years as head of a merger division, to represent clients in a broad range of antitrust and competition matters, including antitrust diligence and deal negotiations, merger reviews and clearances, government investigations, Hart-Scott-Rodino and foreign merger notifications, civil conduct matters, general antitrust compliance, trade association counseling, and antitrust litigation. Having advised clients that range from Fortune 100 firms to not-for-profit entities, his experience spans a wide range of industries, including healthcare, retail, consumer goods, food and beverage, technology products and services, distribution services, veterinary services, financial services, casinos and gaming, pharmaceuticals, biotechnology, digital health, and energy, among others. He has been recognized as a leading antitrust practitioner by Chambers USA, Who’s Who Legal/Global Competition Review, Lawdragon, Legal 500, and The Best Lawyers in America.
Career & Education
- Federal Trade Commission
Bureau of Competition, Mergers IV Division: Assistant Director, 2014–2017;
Deputy Assistant Director, 2012–2014;
Staff Attorney, 2010–2012
- Federal Trade Commission
- Williams College, B.A., 1996
- The George Washington University Law School, J.D., With Honors, 2002
- District of Columbia
- Massachusetts (Inactive)
Professional Activities and Memberships
- Member of the American Bar Association and its Antitrust, Litigation, Business, and Health Law Sections
- Member of The American Health Law Association and its Antitrust, Business Law and Governance, and In-House Counsel Practice Groups
- Member of the Hispanic National Bar Association
Alexis is a proven strategic leader with deep industry understanding and the ability to craft innovative solutions
— Chambers USA, 2024
Alexis's Insights
Press Coverage | 10.30.24
Client Alert | 8 min read | 10.15.24
FTC Significantly Curtails Long-Awaited Changes to HSR Premerger Notification Rules and Procedures
Press Coverage | 09.19.24
Its Own Solar System: A New Purchase For Mars Inc. Will Send It Into The Stratosphere
Firm News | 8 min read | 08.15.24
Representative Matters
- Representing a brick-and-mortar and online food retailer in the FTC and state attorneys general investigation of and litigations challenging Kroger’s acquisition of Albertsons.
- Representing multiple third parties in the FTC’s monopoly maintenance suit against Meta.
- Represented Novant Health in the FTC’s investigation of and litigation challenging the proposed acquisition of two CHS hospitals, successfully defeating the agency’s motion for preliminary injunction in district court (transaction abandoned after injunction pending agency’s appeal).
- Represented an advertising software firm in the FTC’s suit challenging IQVIA’s proposed acquisition of Propel Media.
- Represented an integrated healthcare organization that was target of an FTC investigation of PBM contracting practices focused on insulin products (investigation concluded).
- Represented multiple mortgage-industry firms as third parties in discovery in the FTC’s suit challenging the Intercontinental Exchange/Black Knight transaction.
- Represented a technology company in the FTC’s Broadcom/VMware investigation.
- Represented JAB and National Veterinary Associates in their concurrent $1.1 billion acquisition of SAGE Veterinary Centers and $1.6 billion acquisition of Ethos Veterinary Health (both cleared subject to consent orders).
- Represented a technology company as a third party in the DOJ’s investigation of a wireless-technology transaction.
- Represented a third party technology company in the FTC’s investigation and litigation of NVIDIA’s proposed acquisition of Arm Ltd.
- Represented Dorel Industries in the sale of its Dorel Sports segment to Pon Holdings P.V. for $810 million.
- Represented Novant Health in its $5 billion acquisition of New Hanover Regional Medical Center, the largest hospital acquisition in North Carolina history.
- Represented NorthCrest Health in its sale to HCA’s TriStar Health.
- Represented a veterinary-services provider in its acquisition of nearly 50 facilities from a multi-regional provider.
- Represented Summa Health in its proposed affiliation with Beaumont Health (subsequently abandoned).
- Represented a financial-services firm and its portfolio company in obtaining clearance from the FTC of an acquisition in an area subject to a Prior Notice requirement.
- Represented a leading global manufacturer and marketer of branded consumer foods as a third party in the FTC’s merger investigation of the Post/TreeHouse Foods transaction.
- Represented a marketer and seller of consumer products as a third party in the FTC’s investigation of the Altria/Juul transaction.
- Represented a multinational Fortune 20 healthcare services company as a third party in the FTC’s conduct investigation and litigation against Vyera.
- Represented AT&T in its successful defense of the DOJ’s suit challenging its $108 billion acquisition of Time Warner.
- Represented a Fortune 100 healthcare services company as a third party in an FTC merger investigation.
- Represented a grocery retailer as a third party in an FTC supermarket merger investigation.
- Represented an office products distributor as a third party in an FTC office supplies merger investigation.
- Counsel a national transportation-services provider and energy industry trade association on antitrust compliance issues.
Alexis's Insights
Press Coverage | 10.30.24
Client Alert | 8 min read | 10.15.24
FTC Significantly Curtails Long-Awaited Changes to HSR Premerger Notification Rules and Procedures
Press Coverage | 09.19.24
Its Own Solar System: A New Purchase For Mars Inc. Will Send It Into The Stratosphere
Firm News | 8 min read | 08.15.24
Insights
Court Dismisses Algorithmic Price-Fixing Case, But Opens Door To Amended Complaint
|01.18.24
The Journal of Robotics, Artificial Intelligence & Law
Antitrust Enforcement in the Biden Administration: Five Things to Watch
|06.30.21
Gaming & Leisure (Summer 2021).
Antitrust for Collaborations and Transactions in the Time of COVID-19
|05.07.20
American Health Law Association
Antitrust & COVID-19 in the U.S.: Four Key Issues for Healthcare Providers
|05.01.20
CPI Antitrust Chronicle
“Antitrust Enforcement in 2023: Vertical Mergers, Interlocking Directorates, Unfair Competition, Information Sharing,” Strafford Webinar
|04.20.24
“Antitrust Hot Topics: A Changing Antitrust Landscape,” American Health Law Association Health Care Transactions Conference
|04.17.2023, 04.19.2023
“Assessing the Future of M&A,” The Health Management Academy’s Chief Strategy Officers Forum
|04.03.24
Association of General Counsel Fall Meeting
|10.06.23
“Antitrust Merger Review Process & Analysis,” Institute for Mergers, Acquisitions & Alliances Webinar
|03.24.23
Its Own Solar System: A New Purchase For Mars Inc. Will Send It Into The Stratosphere
|09.19.24
Washington Business Journal
2023's Biggest Health Care Antitrust Developments And What To Expect In 2024
|01.16.24
AHLA's Speaking of Health Law
FTC, DOJ Finalized New Merger Guidelines. Here's What They Mean For Healthcare.
|12.19.23
Advisory Board
A Modern Approach to Retail Mergers
|02.11.19
Crowell & Moring's Retail & Consumer Products Law Observer
Practices
Alexis's Insights
Press Coverage | 10.30.24
Client Alert | 8 min read | 10.15.24
FTC Significantly Curtails Long-Awaited Changes to HSR Premerger Notification Rules and Procedures
Press Coverage | 09.19.24
Its Own Solar System: A New Purchase For Mars Inc. Will Send It Into The Stratosphere
Firm News | 8 min read | 08.15.24